Physician profile
Simon Gringut
NPI 1366769663
$5,161.82
in general payments reported to CMS, 2019-2025
20 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $638 · 2020: $1,615 · 2021: $428 · 2022: $924 · 2023: $544 · 2024: $732 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,556.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,209.23 | 2019-2025 | Watchman Flx, Farapulse, Jetstream Sc |
| Biosense Webster, INC. | $1,082.18 | 2019-2025 | Carto 3, Qdot Micro |
| Medical Device Business Services, INC. | $905.80 | 2020 | |
| Medtronic, INC. | $580.18 | 2021-2023 | Azure Xt Dr Mri Surescan, Micra |
| Abbott Laboratories | $302.12 | 2021-2024 | Amplatzer Amulet |
| Medtronic Vascular, INC. | $299.95 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.23 | 2019-2022 | |
| Amgen INC. | $102.81 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $70.94 | 2021-2024 | Eliquis |
| Ge Healthcare | $66.00 | 2024 | |
| Janssen Pharmaceuticals, INC | $61.55 | 2023-2024 | Xarelto |
| Atricure, INC. | $52.13 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $50.46 | 2019-2022 | |
| Pfizer INC. | $46.08 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.93 | 2023 | Jardiance |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $41.92 | 2023 | |
| Scpharmaceuticals INC. | $21.83 | 2024 | |
| Irhythm Technologies, INC. | $17.79 | 2023 | Zio Xt Patch |
| Actelion Pharmaceuticals US, INC. | $17.22 | 2023 | Opsumit, Uptravi |
| Teleflex LLC | $12.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Gringut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.